Education
About Us
Working with TipRanks
Follow Us
Daniel Starks Insider Profile
4 Followers
Daniel Starks, COB, CEO & Pres, Director at St Jude Medical, holds 7.02M shares in Abbott Labs (Ticker: ABT), holds 6.13M shares in St Jude Medical (Ticker: STJ), holds 60.00K shares in Urologix (Ticker: ULGX).
Daniel Starks St Jude Medical (STJ)COB, CEO & Pres, Director
St Jude Medical (STJ)
COB, CEO & Pres, Director
Ranked #18,361 out of 78,624 Corporate Insiders
Profitable Transactions
6 out of 8 Profitable Transactions
Average Return
+7.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Daniel Starks
Daniel Starks's Trading History
St Jude Medical
Jan 06, 2017
―
Uninformative Sell
―
$495.28M
Abbott Labs
Apr 28, 2020
Director
Uninformative Buy
―
$755.56M
Urologix
―
Director
―
$600.00
List of latest transactions for each holding click on a transaction to see Daniel Starks's performance on stock
You May Also Like
Daniel Starks insider profile FAQ
What is the percentage of profitable transactions made by Daniel Starks?
The percentage of profitable transactions made by Daniel Starks is 75%.
What is the average return per transaction made by Daniel Starks?
The average return per transaction made by Daniel Starks is 7.50%.
What stocks does Daniel Starks hold?
Daniel Starks holds: STJ, ABT, ULGX stocks.
What was Daniel Starks’s latest transaction?
Daniel Starks latest transaction was an Uninformative Buy of ―.
What was Daniel Starks's most profitable transaction?
Daniel Starks’s most profitable transaction was an Informative Buy of ABT stock on August 3, 2017. The return on the trade was 35.20%.
What is Daniel Starks's role in St Jude Medical?
Daniel Starks's role in St Jude Medical is COB, CEO & Pres, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.